Skip to content
10-Q

Quarterly Report

Silo Pharma, Inc. SILO

0001213900-25-110006

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 13.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.33M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.72M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 3.41M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.88M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$2.92M
Short Term Investments Q3 2025 · Sep 30, 2025 $1.95M
Short Term Investments Q3 2025 · Dec 31, 2024 $3.17M
Short Term Investments Q3 2025 · Sep 30, 2024 $3.15M
Short Term Investments Q3 2025 · Dec 31, 2023 $4.14M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.92M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.91M
Stockholders Equity Q3 2025 · Sep 30, 2025 $5.01M
Stockholders Equity Q3 2025 · Jun 30, 2025 $4.92M
Stockholders Equity Q3 2025 · Mar 31, 2025 $4.01M
Stockholders Equity Q3 2025 · Dec 31, 2024 $5.03M
Stockholders Equity Q3 2025 · Sep 30, 2024 $6.78M
Stockholders Equity Q3 2025 · Jun 30, 2024 $5.96M
Stockholders Equity Q3 2025 · Mar 31, 2024 $5.29M
Stockholders Equity Q3 2025 · Dec 31, 2023 $6.18M
Current Liabilities Q3 2025 · Sep 30, 2025 $708.34K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.66M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.38M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.38M
Current Assets Q3 2025 · Sep 30, 2025 $6.16M
Current Assets Q3 2025 · Dec 31, 2024 $7.11M
Total Assets Q3 2025 · Sep 30, 2025 $6.38M
Total Assets Q3 2025 · Dec 31, 2024 $7.41M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.78
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.50
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$0.78
Rd Expense Q3 2025 · Sep 30, 2025 $543.62K
Rd Expense Q3 2025 · Sep 30, 2025 $1.85M
Rd Expense Q3 2025 · Sep 30, 2024 $517.55K
Rd Expense Q3 2025 · Sep 30, 2024 $1.29M
Net Income Q3 2025 · Sep 30, 2025 −$1.11M
Net Income Q3 2025 · Sep 30, 2025 −$3.35M
Net Income Q3 2025 · Jun 30, 2025 −$1.2M
Net Income Q3 2025 · Mar 31, 2025 −$1.03M
Net Income Q3 2025 · Sep 30, 2024 −$928.81K
Net Income Q3 2025 · Sep 30, 2024 −$2.66M
Net Income Q3 2025 · Jun 30, 2024 −$931.78K
Net Income Q3 2025 · Mar 31, 2024 −$801.67K
Operating Income Q3 2025 · Sep 30, 2025 −$1.15M
Operating Income Q3 2025 · Sep 30, 2025 −$3.49M
Operating Income Q3 2025 · Sep 30, 2024 −$1.01M
Operating Income Q3 2025 · Sep 30, 2024 −$2.89M
Gross Profit Q3 2025 · Sep 30, 2025 −$2.66K
Gross Profit Q3 2025 · Sep 30, 2025 $30.47K
Gross Profit Q3 2025 · Sep 30, 2024 $16.57K
Gross Profit Q3 2025 · Sep 30, 2024 $49.7K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $20.69K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $23.61K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.46K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.38K
Revenue Q3 2025 · Sep 30, 2025 $18.03K
Revenue Q3 2025 · Sep 30, 2025 $54.08K
Revenue Q3 2025 · Sep 30, 2024 $18.03K
Revenue Q3 2025 · Sep 30, 2024 $54.08K
Stock Repurchased Q3 2025 · Jan 9, 2024 $1M